Uterotonic Medications: Oxytocin, Methylergonovine, Carboprost, Misoprostol

Anesthesiol Clin. 2017 Jun;35(2):207-219. doi: 10.1016/j.anclin.2017.01.007. Epub 2017 Mar 30.

Abstract

Uterine atony is a common cause of primary postpartum hemorrhage, which remains a major cause of pregnancy-related mortality for women worldwide. Oxytocin, methylergonovine, carboprost, and misoprostol are commonly used to restore uterine tone. Oxytocin is the first-line agent. Methylergonovine and carboprost are both highly effective second-line agents with severe potential side effects. Recent studies have called into question the effectiveness of misoprostol as an adjunct to other uterotonic agents, but it remains a useful therapeutic in resource-limited practice environments. We review the current role these medications play in the prevention and treatment of uterine atony.

Keywords: Carboprost; Methylergonovine; Misoprostol; Oxytocin; Postpartum hemorrhage; Uterine atony; Uterotonic agent.

Publication types

  • Review

MeSH terms

  • Carboprost / adverse effects
  • Carboprost / therapeutic use*
  • Female
  • Humans
  • Methylergonovine / adverse effects
  • Methylergonovine / therapeutic use*
  • Misoprostol / adverse effects
  • Misoprostol / therapeutic use*
  • Oxytocics / adverse effects
  • Oxytocics / therapeutic use*
  • Oxytocin / adverse effects
  • Oxytocin / therapeutic use*
  • Postpartum Hemorrhage / drug therapy*
  • Postpartum Hemorrhage / prevention & control*
  • Pregnancy

Substances

  • Oxytocics
  • Misoprostol
  • Oxytocin
  • Carboprost
  • Methylergonovine